Serotonin syndrome

Australian Prescriber

Volumn 26, Issue 3, 2003, Pages 62-63

  Hall, Michael ^a   Buckley, Nick ^a  

^a CANBERRA HOSPITAL   (Australia)

Author keywords

Cyproheptadine; Drug interactions; Selective serotonin reuptake inhibitors

Indexed keywords

AMPHETAMINE DERIVATIVE; ANOREXIGENIC AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BUSPIRONE; CYPROHEPTADINE; HYPERICUM PERFORATUM EXTRACT; LITHIUM; LYSERGIDE; MONOAMINE OXIDASE INHIBITOR; PETHIDINE; SEROTONIN; SEROTONIN AGONIST; SEROTONIN ANTAGONIST; SEROTONIN UPTAKE INHIBITOR; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT; TRYPTOPHAN;

ARTICLE; AUTONOMIC DYSFUNCTION; CENTRAL NERVOUS SYSTEM; DISEASE SEVERITY; FATALITY; HUMAN; MENTAL DISEASE; NEUROMUSCULAR DISEASE; SEROTONIN SYNDROME;

EID: 0038353560     PISSN: 03128008     EISSN: None     Source Type: Journal    
DOI: 10.18773/austprescr.2003.044     Document Type: Article

References (3)

1. Data produced by Drug Utilisation Sub-Committee, Pharmaceutical Benefits Branch, Health Access and Financing Division, Commonwealth Department of Health and Ageing, Canberra, 2002.
2. Tiller JWG. Medicinal mishaps: serotonin states. Aust Prescr 1998;21:63.
3. Chan BS, Graudins A, Whyte IM, Dawson AH, Braitberg G, Duggin GG. Serotonin syndrome resulting from drug interactions. Med J Aust 1998;169:523-5.